Eva Maria Roes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eva Maria Roes has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Christianne A. R. Lok
Department of Gynaecologic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands
19 shared publications - Jurgen M. J. Piek
Department of Obstetrics and Gynecology and Catharina Cancer Institute Catharina Hospital Eindhoven The Netherlands
19 shared publications - Ronald P. Zweemer
Department of Gynecologic Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
19 shared publications - Cornelis D. de Kroon
Leiden University Medical Center, Leiden, The Netherlands
18 shared publications - Geertruid J. Brink
Department of Gynecologic Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
18 shared publications - Hans. W. Nijman
Department of Gynecology, University Medical Center Groningen, Groningen, The Netherlands
18 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Elsevier in SSRN Electronic Journal
Fertility and pregnancy concerns and needs after fertility-sparing surgery in young women with gynecological cancer and their partners: a qualitative study
Introduction: Many young women treated for gynecological cancer are assumed to experience long-term concerns about fertility and pregnancy, and psychological distress. However, evidence on patients’ post-treatment reproductive concerns, decisions to pursue pregnancy, and oncofertility needs is limited. This study aims to provide insight into the perspectives of women treated with fertility-sparing surgery (FSS) for gynecological cancer and their partners.Methods: Women and their partners were selected for semi-structured interviews from our previously performed questionnaire study through purposive sampling based on self-reported reproductive concerns and pregnancy attempts.Results: Data saturation was achieved after 32 interviews with 24 women and eight partners. Three women refrained from pursuing pregnancy. Many women expressed reproductive concerns and encounter post-treatment challenges, including a sense of time pressure, fear of cancer recurrence, and a common need for assisted reproductive techniques. Nearly all women expressed their need for post-operative fertility counseling, although the preferred timing for this support varied. Partners considered their primary role as providing support throughout the treatment (decision) process, deciding to conceive and pursuing pregnancy. Some partners emphasized the importance, but lack of partner support.Conclusions: Women treated with FSS for gynecological cancer and their partners face persistent uncertainty regarding fertility and pregnancy, yet most women remain motivated to pursue pregnancy. Partners play a supportive role, but also have unmet needs. These findings highlight that reproductive issues should be systematically incorporated into routine clinical care pathways.
- 22 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFertility and pregnancy concerns and needs after fertility-sparing surgery in young women with gynecological cancer and their partners: a qualitative study
Introduction: Many young women treated for gynecological cancer are assumed to experience long-term concerns about fertility and pregnancy, and psychological distress. However, evidence on patients’ post-treatment reproductive concerns, decisions to pursue pregnancy, and oncofertility needs is limited. This study aims to provide insight into the perspectives of women treated with fertility-sparing surgery (FSS) for gynecological cancer and their partners.Methods: Women and their partners were selected for semi-structured interviews from our previously performed questionnaire study through purposive sampling based on self-reported reproductive concerns and pregnancy attempts.Results: Data saturation was achieved after 32 interviews with 24 women and eight partners. Three women refrained from pursuing pregnancy. Many women expressed reproductive concerns and encounter post-treatment challenges, including a sense of time pressure, fear of cancer recurrence, and a common need for assisted reproductive techniques. Nearly all women expressed their need for post-operative fertility counseling, although the preferred timing for this support varied. Partners considered their primary role as providing support throughout the treatment (decision) process, deciding to conceive and pursuing pregnancy. Some partners emphasized the importance, but lack of partner support.Conclusions: Women treated with FSS for gynecological cancer and their partners face persistent uncertainty regarding fertility and pregnancy, yet most women remain motivated to pursue pregnancy. Partners play a supportive role, but also have unmet needs. These findings highlight that reproductive issues should be systematically incorporated into routine clinical care pathways.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of CTRL+ cell line
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of CTRL+ cell line
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Methods S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Protocol cell culture and drug screen
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessMethods S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Protocol cell culture and drug screen
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Growth rate and passage number overview
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Growth rate and passage number overview
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of several locations per patient
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of several locations per patient
- Open Access
- 2 April 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of several locations per patient
- 2 April 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors
Drug screen response of several locations per patient